FENC logo

Fennec Pharmaceuticals (FENC) Accounts Receivable

Annual Accounts Receivable

$8.81 M
+$7.27 M+470.49%

December 31, 2023


Summary


Performance

FENC Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCbalance sheetmetrics:

Quarterly Accounts Receivable

$12.91 M
+$596.00 K+4.84%

September 30, 2024


Summary


Performance

FENC Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

FENC Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+470.5%+4.8%
3 y3 years-+667.0%
5 y5 years-+667.0%

FENC Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-100.0%at high-100.0%
5 y5-yearat high-100.0%at high-100.0%
alltimeall timeat high-100.0%at high-100.0%

Fennec Pharmaceuticals Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$12.91 M(+4.8%)
Jun 2024
-
$12.31 M(+19.8%)
Mar 2024
-
$10.27 M(+16.6%)
Dec 2023
$8.81 M(+470.5%)
$8.81 M(+94.8%)
Sep 2023
-
$4.53 M(+85.1%)
Jun 2023
-
$2.44 M(+45.3%)
Mar 2023
-
$1.68 M(+8.9%)
Dec 2022
$1.54 M(>+9900.0%)
$1.54 M(>+9900.0%)
Dec 2021
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2010
-
$1000.00(>+9900.0%)
Jun 2010
-
$0.00(-100.0%)
Mar 2010
-
$43.00 K(-37.7%)
Dec 2009
$69.00 K(+1050.0%)
$69.00 K(+1050.0%)
Dec 2008
$6000.00(-71.4%)
$6000.00(-81.8%)
Sep 2008
-
$33.00 K(-10.8%)
Jun 2008
-
$37.00 K(+15.6%)
Mar 2008
-
$32.00 K(+52.4%)
Dec 2007
$21.00 K(-34.4%)
$21.00 K(-64.4%)
Sep 2007
-
$59.00 K(-11.9%)
Jun 2007
-
$67.00 K(+26.4%)
Mar 2007
-
$53.00 K(+65.6%)
Dec 2006
$32.00 K
$32.00 K(+100.0%)
DateAnnualQuarterly
Sep 2006
-
$16.00 K(-5.9%)
Jun 2006
-
$17.00 K(+13.3%)
Mar 2006
-
$15.00 K(0.0%)
Dec 2005
$15.00 K(-61.5%)
$15.00 K(-63.4%)
Sep 2005
-
$41.00 K(+355.6%)
Jun 2005
-
$9000.00(-52.6%)
Mar 2005
-
$19.00 K(-63.5%)
Sep 2004
-
$52.00 K(+33.3%)
Jun 2004
$39.00 K(+74.9%)
$39.00 K(-27.9%)
Mar 2004
-
$54.10 K(+20.2%)
Dec 2003
-
$45.00 K(+48.0%)
Sep 2003
-
$30.40 K(+36.3%)
Jun 2003
$22.30 K(-83.9%)
$22.30 K(-82.4%)
Mar 2003
-
$126.90 K(+92.3%)
Dec 2002
-
$66.00 K(-52.4%)
Jun 2002
$138.60 K(+2.7%)
$138.60 K(+58.8%)
Mar 2002
-
$87.30 K(-57.0%)
Dec 2001
-
$202.90 K(+57.8%)
Sep 2001
-
$128.60 K(-4.7%)
Jun 2001
$135.00 K(+351.5%)
$135.00 K(+9.8%)
Dec 2000
-
$123.00 K
Jun 2000
$29.90 K
-

FAQ

  • What is Fennec Pharmaceuticals annual accounts receivable?
  • What is the all time high annual accounts receivable for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals annual accounts receivable year-on-year change?
  • What is Fennec Pharmaceuticals quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals quarterly accounts receivable year-on-year change?

What is Fennec Pharmaceuticals annual accounts receivable?

The current annual accounts receivable of FENC is $8.81 M

What is the all time high annual accounts receivable for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high annual accounts receivable is $8.81 M

What is Fennec Pharmaceuticals annual accounts receivable year-on-year change?

Over the past year, FENC annual accounts receivable has changed by +$7.27 M (+470.49%)

What is Fennec Pharmaceuticals quarterly accounts receivable?

The current quarterly accounts receivable of FENC is $12.91 M

What is the all time high quarterly accounts receivable for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high quarterly accounts receivable is $12.91 M

What is Fennec Pharmaceuticals quarterly accounts receivable year-on-year change?

Over the past year, FENC quarterly accounts receivable has changed by +$596.00 K (+4.84%)